Cardiovascular autonomic testing performed with a new integrated instrumental approach is useful in differentiating MSA-P from PD at an early stage.

[1]  Ivan Corazza,et al.  A new integrated instrumental approach to autonomic nervous system assessment , 2014, Comput. Methods Programs Biomed..

[2]  G. Deuschl,et al.  Time to Redefine PD? Introductory Statement of the MDS Task Force on the Definition of Parkinson's Disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[3]  A. Bentivoglio,et al.  Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy , 2014, Journal of the Neurological Sciences.

[4]  G. Lopane,et al.  Multiple system atrophy with prolonged survival: is late onset of dysautonomia the clue? , 2013, Neurological Sciences.

[5]  H. Sawada,et al.  Diagnostic Accuracy of Apparent Diffusion Coefficient and 123I-Metaiodobenzylguanidine for Differentiation of Multiple System Atrophy and Parkinson’s Disease , 2013, PloS one.

[6]  Günther Deuschl,et al.  The natural history of multiple system atrophy: a prospective European cohort study , 2013, The Lancet Neurology.

[7]  S Strano,et al.  The potential prognostic role of cardiovascular autonomic failure in α‐synucleinopathies , 2013, European journal of neurology.

[8]  L. Hazrati,et al.  Multiple system atrophy–parkinsonism with slow progression and prolonged survival: A diagnostic catch , 2012, Movement disorders : official journal of the Movement Disorder Society.

[9]  Michael Camilleri,et al.  The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy , 2012, Journal of the Neurological Sciences.

[10]  Samay Jain,et al.  Cardiovascular dysautonomia in Parkinson disease: From pathophysiology to pathogenesis , 2012, Neurobiology of Disease.

[11]  S. Gilman,et al.  Autopsy confirmed multiple system atrophy cases: Mayo experience and role of autonomic function tests , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  D. Low,et al.  Cardiovascular autonomic dysfunction in MSA and Parkinson's disease: Similarities and differences , 2011, Journal of the Neurological Sciences.

[13]  R. Freeman,et al.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome , 2011, Autonomic Neuroscience.

[14]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[15]  G. Wenning,et al.  Multiple system atrophy: an update , 2009, The Lancet Neurology.

[16]  H. Reichmann,et al.  Valsalva manoeuvre in patients with different Parkinsonian disorders , 2009, Journal of Neural Transmission.

[17]  Sid Gilman,et al.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. , 2009, Archives of neurology.

[18]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[19]  W. Poewe,et al.  Diffusion weighted imaging best discriminates PD from MSA‐P: A comparison with tilt table testing and heart MIBG scintigraphy , 2007, Movement disorders : official journal of the Movement Disorder Society.

[20]  P. Sandroni,et al.  Blood pressure recovery from Valsalva maneuver in patients with autonomic failure , 2005, Neurology.

[21]  D. Purohit,et al.  Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies , 2004, Neurology.

[22]  D. Goldstein,et al.  Plasma levels of catechols and metanephrines in neurogenic orthostatic hypotension , 2003, Neurology.

[23]  D. Riley,et al.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[24]  E. Benarroch.  New findings on the neuropathology of multiple system atrophy , 2002, Autonomic Neuroscience.

[25]  M. Elam,et al.  Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes , 2001, Movement disorders : official journal of the Movement Disorder Society.

[26]  N P Quinn,et al.  What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease? , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  O. Rascol,et al.  Prevalence of orthostatic hypotension in Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[28]  JR Kimber,et al.  Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine , 1997, The Lancet.

[29]  P. Sandroni,et al.  Autonomic involvement in extrapyramidal and cerebellar disorders , 1991, Clinical Autonomic Research.

[30]  D. Ewing.  TESTING FOR AUTONOMIC NEUROPATHY , 1981, The Lancet.

[31]  H. Reichmann,et al.  Comprehensive autonomic assessment does not differentiate between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy , 2009, Journal of Neural Transmission.

[32]  S. Gilman,et al.  Diagnostic criteria for Parkinson disease. , 1999, Archives of neurology.